Libmeldy, world’s first lentiviral vector-based gene therapy for the treatment of metachromatic leukodystrophy (MLD)
22 Dicembre 2020
The European Commission officially announced full approval for the world’s first lentiviral vector-based gene therapy for the treatment of metachromatic leukodystrophy (MLD), a rare neurodegenerative
